logoTry Persana

Signatur Biosciences - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Signatur Biosciences including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Signatur Biosciences company logo

Making precision diagnostics accessible.

Signatur Biosciences makes precision diagnostics more accessible, focusing on breast cancer testing.

HeadquartersLondon, United Kingdom
Team size1-50
Founded2022

What is Signatur Biosciences? - Company Overview & Details

Signatur Biosciences is Signatur Biosciences makes precision diagnostics more accessible, focusing on breast cancer testing. Founded in 2022, the company is headquartered in London, United Kingdom.

Who Founded Signatur Biosciences?

Signatur Biosciences was founded by Celestin de Wergifosse.

Who are the Key Executives at Signatur Biosciences? - Leadership Team

Signatur Biosciences is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Signatur Biosciences

Celestin de WergifosseCEO

Chief Technology Officer (CTO) of Signatur Biosciences

CTO

About Celestin de Wergifosse - CEO of Signatur Biosciences

Celestin de Wergifosse serves as the Chief Executive Officer of Signatur Biosciences, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Signatur Biosciences Company Details & Key Information

Where is Signatur Biosciences located?

Signatur Biosciences is headquartered in London, United Kingdom.

How many employees does Signatur Biosciences have?

Signatur Biosciences has 1-50 employees.

When was Signatur Biosciences founded?

Signatur Biosciences was founded in 2022.

Signatur Biosciences Official Website

How much funding has Signatur Biosciences raised?

Signatur Biosciences has raised $9.9 Million across 3 funding rounds. The most recent funding was completed on 2025-05-28.

Funding Overview

Signatur Biosciences has raised a total of $9.9 million, including a recent $7 million seed round.

$9.9 Million
Total Funding Raised
3
Funding Rounds
2025-05-28
Latest Round

Signatur Biosciences Funding History

Pre seed
2022-09-23
$500,000
Seed
2025-05-28
$7,000,000

Who are the key investors in Signatur Biosciences?

Signatur Biosciences is backed by 2 key investors including Y Combinator, Ion Beam Applications. These investors focus on Biotechnology, Healthcare, Radiation Therapy sectors.

Signatur Biosciences Investor Overview

2
Key Investors
3
Focus Areas
0
Notable Investments

Complete List of Signatur Biosciences Investors

Y Combinator

A startup accelerator that supports early-stage companies.

Investment Focus
Biotechnology
Healthcare

Ion Beam Applications

A leading global provider of advanced radiation therapy solutions.

Investment Focus
Radiation Therapy

What sectors do Signatur Biosciences investors focus on?

The investors backing Signatur Biosciences primarily focus on Biotechnology, Healthcare, Radiation Therapy sectors.

Biotechnology
Healthcare
Radiation Therapy

Featured Investor: Y Combinator

Y Combinator

A startup accelerator that supports early-stage companies.

Notable Investments:

What are Signatur Biosciences's future plans?

Signatur Biosciences Signatur Biosciences aims to expand its team and develop innovative diagnostics.

Signatur Biosciences Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Signatur Biosciences face?

Signatur Biosciences has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Signatur Biosciences

1

Market competition

2

Funding for future growth

What opportunities does Signatur Biosciences have?

Signatur Biosciences has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Signatur Biosciences

1

Expansion into new markets

2

Development of new diagnostic products

Signatur Biosciences Strategic Position Summary

Key Focus Areas

Signatur Biosciences is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Signatur Biosciences?

Signatur Biosciences has 2 recent news updates covering key business developments and market activities.

Signatur Biosciences News Overview

2
Recent Articles
Active
Media Coverage
2025-05-23
Latest Update

What is Signatur Biosciences in the news for?

Signatur Biosciences is currently featured in news for Signatur Biosciences Closes $7M Seed Round and other significant business developments.

Recent News Articles About Signatur Biosciences

Article 1
2025-05-23

Signatur Biosciences Closes $7M Seed Round

The company has closed its $7 million seed round to further enhance its cancer diagnostic solutions.

Read News
Article 2
2025-02-21

Awarded Phase 1 of SBRI Healthcare Grant

Signatur Biosciences received funding to support innovation in Women's Health.

Read News

Signatur Biosciences FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Signatur Biosciences including information about founders, CEO, funding history, investors, headquarters location, and company details. 18 frequently asked questions covering key information about the company.

Signatur Biosciences Questions & Answers - Company Information

Q1

What is Signatur Biosciences?

Signatur Biosciences makes precision diagnostics more accessible, focusing on breast cancer testing.

Q2

Who founded Signatur Biosciences?

Signatur Biosciences was founded by Celestin de Wergifosse.

Q3

Who is the CEO of Signatur Biosciences?

The CEO of Signatur Biosciences is Celestin de Wergifosse. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Signatur Biosciences raised?

Signatur Biosciences has raised a total of $$9.9 Million across 3 funding rounds. The most recent funding was completed on 2025-05-28.

Q5

Who are the investors in Signatur Biosciences?

Signatur Biosciences's key investors include Y Combinator, Ion Beam Applications.

Q6

Where is Signatur Biosciences headquartered?

Signatur Biosciences is headquartered in London, United Kingdom.

Q7

When was Signatur Biosciences founded?

Signatur Biosciences was founded in 2022.

Q8

How many employees does Signatur Biosciences have?

Signatur Biosciences has 1-50 employees.

Q9

What is Signatur Biosciences's official website?

You can visit Signatur Biosciences's official website at https://www.signatur.bio/.

Q10

What was Signatur Biosciences's latest funding round?

Signatur Biosciences's latest funding round was a Pre seed round of $$500,000 completed on 2022-09-23.

Q11

Who is founder?

Celestin de Wergifosse

Q12

What does the company do?

Signatur Biosciences develops and provides precision diagnostics for breast cancer.

Q13

How much funding?

$9.9 Million

Q14

Latest funding date?

2025-05-28

Q15

Who are the investors?

Y Combinator Ion Beam Applications

Q16

What are the challenges?

Market competition Funding for future growth

Q17

What are the opportunities?

Expansion into new markets Development of new diagnostic products

Q18

Latest news?

The company has closed its $7 million seed round to further enhance its cancer diagnostic solutions. Signatur Biosciences received funding to support innovation in Women's Health.

More Information About Signatur Biosciences

For additional details about Signatur Biosciences, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.